admin

Economic Security Planning, Inc. Today’s column addresses questions about when earned delayed retirement credits (DRCs) are applied to retirement benefits, effects on benefits of selling a home, spousal benefits’ effects on retroactive retirement benefits and options after working while on disability. Larry Kotlikoff is a Professor of Economics at Boston University and the founder and
0 Comments
Aaron Marshall is CEO & Co-Founder of Keyrenter Property Management, the nation’s leading property management and real estate franchise. getty When starting a business, one of the biggest pressures we put on ourselves is to have this outstanding, never-before-seen concept or idea. Yet every professional businessman or woman will point to a certain person or company and
0 Comments
Technicians work on machinery at the Applied Materials facility in Santa Clara, California. David Paul Morris | Bloomberg | Getty Images Check out the companies making headlines after the bell Thursday: Applied Materials — Shares of Applied Materials rose 1.2% in after-hours trading on the back of fiscal third-quarter results that beat analyst expectations. The
0 Comments
By Richard Harris, Next Avenue Contributor Winnona Merritt, who has one of these advance directives David Gilmer Not since the Spanish flu pandemic of 1918 has this country contemplated the unthinkable: rationing vital medical resources on a wide scale. Since the first confirmed case of Covid-19 in the U.S. in January, the pandemic has raised fears
0 Comments
getty Close study of the Tax Cuts and Jobs Act appeared to give a fantastic break to businesses with less than $25 million in gross receipts. It appeared that they could change accounting methods and write off their inventories. Lucien Gauthier of the Boston Tax Institute promoted the concept, as I explained in Tax Cut
0 Comments
SoftBank Group chairman and CEO Masayoshi Son. (Photo by Tomohiro Ohsumi/Getty Images) Getty Images This spring, SoftBank, the Japanese conglomerate helmed by Masayoshi Son, backtracked on an offer to buy up to $3 billion of WeWork shares, a deal that would have netted the coworking firm’s cofounder Adam Neumann nearly $1 billion. It seemed, at
0 Comments
When the Covid-19 pandemic struck the U.S., young biotech company Verve Therapeutics was just months away from a pivotal development: studies in animals of its gene-editing approach to lowering cholesterol that would lead it to be heralded as a potential “cure for heart disease.” But Chief Executive Dr. Sekar Kathiresan had a problem: this isn’t
0 Comments